Target- |
MechanismT lymphocytes stimulants |
|
|
|
|
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Emvolio, Inc.
0 Patents (Medical) associated with Emvolio, Inc.
100 Deals associated with Emvolio, Inc.
100 Translational Medicine associated with Emvolio, Inc.